Dr. Sawyer on LBM Outcomes With Siltuximab in Multicentric Castleman's Disease
August 26th 2014Michael Sawyer, MD, associate professor, Medical Oncology, University of Alberta, discusses lean body mass (LBM) outcomes in patients with multicentric Castleman's disease who received siltuximab (Sylvant).
Read More